Free Trial
→ BREAKING: The House just passed 3 pro-crypto bills! (From Crypto 101 Media) (Ad) Free NLSPW Stock Alerts

NLS Pharmaceutics (NLSPW) SEC Filings & 10K Form

NLS Pharmaceutics logo
$0.02 +0.00 (+7.14%)
As of 08/8/2025 11:57 AM Eastern
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/06/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:32 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
07/17/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
6:31 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:57 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13D
06/23/2025
4:29 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
06/16/2025
6:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
6:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
06/10/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
7:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
05/01/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Why AMZN, GOOG, MSFT might destroy NVDA (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
12/30/2024
7:52 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSPW) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsored
Man Who Called Nvidia at $1.10 Says Buy This Now...
In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...
The Oxford Club | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored
FOUR TRILLION DOLLARS!
Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....
Porter & Company | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored